Related Experiment Video
Updated: Aug 6, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Molecular and cellular biology of basal cell carcinoma
Tony Dicker1, Gregory Siller, Nicholas Saunders
1Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia.
Abstract:
The finding of mutations in the PTCH gene in both Gorlin's syndrome and sporadic basal cell carcinomas has significantly advanced our understanding of the molecular defects that lead to the formation of these tumours. Knowledge of the specific molecular and functional changes that have taken place in these tumours will help us devise more defined therapies, as well as give us a better understanding of normal molecular pathways involved in skin development and function. The following is a summary of our current understanding of the molecular and cellular biology of basal cell carcinoma.
Insights
Mutations in the PTCH gene are key to Gorlin's syndrome and basal cell carcinomas. Understanding these genetic changes aids in developing targeted therapies and skin development insights.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Basal cell carcinoma (BCC) is the most common human cancer.
- Gorlin's syndrome, a rare genetic disorder, predisposes individuals to BCC.
- The PTCH gene is implicated in the development of both conditions.
Purpose of the Study:
- To summarize current knowledge on the molecular and cellular biology of basal cell carcinoma.
- To highlight the role of PTCH gene mutations in BCC development.
- To explore the implications for targeted therapy and understanding skin development.
Main Methods:
- Review of existing literature on PTCH gene mutations in BCC and Gorlin's syndrome.
- Analysis of molecular and cellular pathways involved in tumor formation.
- Synthesis of findings to provide a comprehensive overview.
Main Results:
- PTCH gene mutations are a significant factor in the molecular pathology of BCC.
- These mutations disrupt normal cellular pathways, leading to uncontrolled cell growth.
- Understanding these defects is crucial for therapeutic strategies.
Conclusions:
- PTCH gene mutations are central to the pathogenesis of basal cell carcinoma and Gorlin's syndrome.
- Further research into these molecular defects will inform the development of novel cancer therapies.
- This knowledge enhances our understanding of fundamental skin development and function.
More Related Videos
08:09CUBIC Protocol Visualizes Protein Expression at Single Cell Resolution in Whole Mount Skin Preparations
Published on: August 4, 2016
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Basal Lamina are the Specialized Form of ECM
Proteins...
Laminins are the Adhesive Proteins of Basal Lamina
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...